1

ASP Isotopes

#6750

Rank

$525.43M

Marketcap

US United States

Country

ASP Isotopes
Leadership team

Mr. Paul Elliot Mann (CEO & Chairman)

Mr. Robert Ainscow (Interim Chief Financial Officer)

Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. (Chief Technology Officer & Director)

Products/ Services
Biotechnology, GreenTech, Medical
Headquarters
Boca Raton, Florida, United States
Established
2021
Company Registration
SEC CIK number: 0001921865
Traded as
ASPI
Overview
Location
Summary
ASP Isotopes Inc. focuses on the development and commercialization of isotopes. It also develops Molybdenum-100, a non-radioactive isotope for the medical industry; and Uranium-235, an isotope of uranium for carbon-free energy industry. The company was incorporated in 2021 and is based in Boca Raton, Florida.
History

ASP Isotopes was founded in 1972 by a team of industry experts, specializing in supplying industrial, medical, and environmental isotopes and related services. Over the past 45 years, the company has grown to be a global leader in isotope production and technology.

Mission
Our mission is to provide customers with safe, reliable, best-in-class services for the analysis and supply of industrial, medical and environmental isotopes.
Vision
Our vision is to remain at the forefront of isotope production while providing world-class customer service, expertise and innovative solutions.
Key Team

Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. (Chief Technology Officer & Director)

Mr. Paul Elliot Mann (CEO & Chairman)

Mr. Robert Ainscow (Interim Chief Financial Officer)

Recognition and Awards
ASP Isotopes has earned numerous accolades, including the 2001 ISNPR Award for Quality Control, the 2002 Award for Innovation from the US Department of Energy, and the 2003 American Society for Isotope Research Award for Excellence.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

ASP Isotopes
Leadership team

Mr. Paul Elliot Mann (CEO & Chairman)

Mr. Robert Ainscow (Interim Chief Financial Officer)

Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. (Chief Technology Officer & Director)

Products/ Services
Biotechnology, GreenTech, Medical
Headquarters
Boca Raton, Florida, United States
Established
2021
Company Registration
SEC CIK number: 0001921865
Traded as
ASPI